Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Branded Medicines Tranche B - Lot 1 - London & South of England - CM/PHR/25/5731
Period of Framework Agreement: 1 September 2026 to 31 August 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Lot 2 - Ustekinumab for North of England and Midlands & East, period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Framework contract: £813,863,584 total value shared among 27 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| ABBVIE LTD | Procurement ID: PHRQ-1133-WGCH | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ACCORD-UK LTD | Procurement ID: PBTN-3137-DHTG | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ALFASIGMA UK LIMITED | Procurement ID: PYDW-6316-ZVYQ | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| AMGEN LIMITED | Procurement ID: PDJG-8184-TCQQ | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| AVENTIS PHARMA LIMITED | Procurement ID: PMBG-8218-QDPT | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| AVENTIS PHARMA LIMITED t-a Sanofi | Procurement ID: PMBG-8218-QDPT | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| BIOGEN IDEC LIMITED | Procurement ID: PTGT-3385-PBMQ | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| BIOSIMILAR COLLABORATIONS IRELAND LIMITED | Procurement ID: PQQC-5869-LMVX | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| CELLTRION HEALTHCARE UK LIMITED | Procurement ID: PYQL-4248-PXXY | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | Procurement ID: PYQL-4248-PXXY | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| DR REDDY'S LABORATORIES (UK) LIMITED | Procurement ID: PGGG-3877-XTJG | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| FRESENIUS KABI LIMITED | Procurement ID: PZVH-4892-PJYY | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| GEDEON RICHTER (UK) LIMITED | Procurement ID: PVNN-9371-ZTBW | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| GLAXOSMITHKLINE UK LIMITED | Procurement ID: PNVC-2547-YXMP | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| JANSSEN-CILAG LIMITED | Procurement ID: PTBW-9923-RLZD | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| MILPHARM LIMITED | Procurement ID: PCYZ-5538-QLGR | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ORGANON PHARMA (UK) LIMITED | Procurement ID: PTZC-8956-NPPT | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ORIFARM UK LTD | Procurement ID: PQPW-1715-PJLT | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| PFIZER LIMITED | Procurement ID: PCQW-3224-CMTG | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ROCHE PRODUCTS LIMITED | Procurement ID: PXCG-4172-CHYM | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| SAMSUNG BIOEPIS UK LIMITED | Procurement ID: PNBG-7778-YPZQ | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| SANDOZ LIMITED | Procurement ID: PNQL-1548-CYBZ | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| SWEDISH ORPHAN BIOVITRUM LTD | Procurement ID: PNNT-2898-LYZL | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| TEVA UK LIMITED | Procurement ID: PWDD-6894-DXRM | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| THORNTON & ROSS LIMITED | Procurement ID: PWYH-6892-QYNN | ~£30,143,096 | 2 lots Lot 1 - Tranche B for London & South of England · Lot 2 - Ustekinumab for North of England and Midlands & East | - |
| UCB PHARMA LIMITED | Procurement ID: PBPB-9589-WWBY | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
| ZENTIVA PHARMA UK LIMITED | Procurement ID: PJTB-3347-PLGW | ~£30,143,096 | 1 lot Lot 1 - Tranche B for London & South of England | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 2 lots, each awarded separately. 34 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Lot 1 - Tranche B for London & South of England Sept 2026 – Aug 2028 | £541,494,660 £813,863,584 initial term | 26 | AMGEN LIMITED Alfasigma UK Limited FRESENIUS KABI LIMITED CELLTRION HEALTHCARE UNITED KINGDOM LIMITED ROCHE PRODUCTS LIMITED Biosimilar Collaborations Ireland Limited THORNTON & ROSS LIMITED GLAXOSMITHKLINE UK LIMITED SAMSUNG BIOEPIS UK LIMITED DR REDDY'S LABORATORIES (UK) LIMITED SANDOZ LIMITED PFIZER LIMITED ACCORD-UK LTD ABBVIE LTD BIOGEN IDEC LIMITED JANSSEN-CILAG LIMITED ORIFARM UK LTD ORGANON PHARMA (UK) LIMITED ZENTIVA PHARMA UK LIMITED SWEDISH ORPHAN BIOVITRUM LTD MILPHARM LIMITED AVENTIS PHARMA LIMITED UCB PHARMA LIMITED TEVA UK LIMITED GEDEON RICHTER (UK) LIMITED ALFASIGMA UK LIMITED AVENTIS PHARMA LIMITED t-a Sanofi BIOSIMILAR COLLABORATIONS IRELAND LIMITED CELLTRION HEALTHCARE UK LIMITED | active |
| Lot 2 Lot 2 - Ustekinumab for North of England and Midlands & East Sept 2026 – Aug 2027 | £50,868,757 £18,903,212 initial term | 8 | THORNTON & ROSS LIMITED SANDOZ LIMITED JANSSEN-CILAG LIMITED GEDEON RICHTER (UK) LIMITED FRESENIUS KABI LIMITED CELLTRION HEALTHCARE UNITED KINGDOM LIMITED BIOGEN IDEC LIMITED AMGEN LIMITED BIOSIMILAR COLLABORATIONS IRELAND LIMITED CELLTRION HEALTHCARE UK LIMITED | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| AMGEN LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| BIOGEN IDEC LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| FRESENIUS KABI LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| GEDEON RICHTER (UK) LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| JANSSEN-CILAG LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| SANDOZ LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| THORNTON & ROSS LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| ABBVIE LTD | Lot 1 | Wonlot 1 |
| ACCORD-UK LTD | Lot 1 | Wonlot 1 |
| Alfasigma UK Limited | Lot 1 | Wonlot 1 |
| AVENTIS PHARMA LIMITED | Lot 1 | Wonlot 1 |
| Biosimilar Collaborations Ireland Limited | Lot 1 | Wonlot 1 |
| DR REDDY'S LABORATORIES (UK) LIMITED | Lot 1 | Wonlot 1 |
| GLAXOSMITHKLINE UK LIMITED | Lot 1 | Wonlot 1 |
| MILPHARM LIMITED | Lot 1 | Wonlot 1 |
| ORGANON PHARMA (UK) LIMITED | Lot 1 | Wonlot 1 |
| ORIFARM UK LTD | Lot 1 | Wonlot 1 |
| PFIZER LIMITED | Lot 1 | Wonlot 1 |
| ROCHE PRODUCTS LIMITED | Lot 1 | Wonlot 1 |
| SAMSUNG BIOEPIS UK LIMITED | Lot 1 | Wonlot 1 |
| SWEDISH ORPHAN BIOVITRUM LTD | Lot 1 | Wonlot 1 |
| TEVA UK LIMITED | Lot 1 | Wonlot 1 |
| UCB PHARMA LIMITED | Lot 1 | Wonlot 1 |
| ZENTIVA PHARMA UK LIMITED | Lot 1 | Wonlot 1 |
| TAKEDA UK LIMITED | Lot 1 | Unsuccessful |
Weightings from the notice, applied to every lot.
Changes the buyer published to this notice after it first appeared.
Updated to Above Threshold Tender
Registration starts date updated